Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

ROTH MKM Announces the Addition of Dylan Dupuis, Ph.D. to its Healthcare Research Team

ROTH MKM (“Roth”), www.roth.com, a relationship-driven investment bank focused on serving emerging growth companies and their investors, today announced that Dr. Dylan Dupuis has joined the firm’s healthcare research team, as Managing Director, Senior Research Analyst covering biotechnology. His research coverage is expected to include micro-cap and small-cap Biotechnology companies across the therapeutic space, with an initial focus on companies developing novel drugs for immunology, inflammatory diseases, metabolic diseases, and oncology.

Prior to joining ROTH MKM, Dr. Dupuis was a SMID-cap Biotech Analyst at Altium Capital, a healthcare-focused hedge fund. Prior to Altium, he spent two years at SVB Leerink as VP - Equity Research, Senior Associate. Prior to SVB Leerink, he was a Research Associate at B. Riley FBR. Dr. Dupuis received his Ph.D. in Molecular Biology from Lehigh University focused on A-to-I RNA editing and completed a Post-Doctoral Research Fellowship at the Center for Vascular Biology Research at Beth Israel Deaconess Medical Center, Harvard Medical School. He received his B.S. in Biology and Chemistry from Lycoming College.

Jeff Martin, CFA – Co-Director of Research, commented, “ROTH MKM continues to invest in biotechnology research talent to enhance the strength of our Healthcare platform. I’m pleased to welcome Dylan to our thought-leading biotechnology research team. His strong academic background combined with his experience covering innovative and underappreciated biotechnology companies will undoubtedly serve our clients well.”

Dr. Dupuis commented, “I am thrilled to be joining ROTH MKM, which holds a strong history in healthcare. I look forward to contributing to its legacy of providing high-quality, in-depth, fundamental research. My goal is to focus on innovative technology grounded by excellent science that aims to address unmet medical needs, while providing favorable risk-reward for investors.”

“We are excited to have Dylan join our healthcare research team,” said Sagar Sheth, CEO of ROTH MKM. “His diverse experience in a variety of therapeutic areas is an excellent fit for our biotechnology research platform. I’m confident that Dylan’s expertise in biotechnology will provide valuable insights for clients and help build upon our long track record in the healthcare sector.”

Since 2010, ROTH MKM has been involved in approximately 570 transactions for its Healthcare clients, with total transaction value over $25 billion. (Source: ROTH MKM | 3/10/23)

About ROTH MKM

ROTH MKM is a relationship-driven investment bank focused on serving growth companies and their investors. Our full service platform provides capital raising, high impact equity research, macroeconomics, sales and trading, technical insights, derivatives strategies, M&A advisory and corporate access. Headquartered in Newport Beach, California, ROTH MKM is a privately-held, employee owned organization and maintains offices throughout the U.S. For more information, please visit www.roth.com.

Contacts

Investor and Media Contact: ROTH MKM, Isabel Mattson-Pain, Director of Marketing, Imattson-pain@roth.com, 949-720-7117.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.